In a new study published in the Cell Press journal “Chemistry & Biology”, researchers in the Chen lab share a discovery that could lead to a new strategy for sensitizing radiation-resistant cancer cells to the treatment.
“Proteomics and Precision Medicine”
“Top Down Proteomics for Precise Description of KRAS Gene Products in Colorectal Cancer”
The University of North Carolina at Chapel Hill, Washington University School of Medicine in St. Louis, and Boise State University have been named partners in one of five US centers that will use genetic data to search for proteins that are abnormally made by cancer cells. The partnerships form the new Clinical Proteomic Tumor Analysis Consortium (CPTAC) supported by the National Cancer Institute (NCI).
This section began with information courtesy of Dr. Thomas Traut in 2008. The Department of Biological Chemistry became an independent academic unit in 1935. In the earlier years of the twentieth century, the subject of biochemistry had been taught at UNC-Chapel Hill by professors holding an appointment within the Department of Physiology. Before 1938, biochemistry … Read more
In a study in Nature Communications, Pengda Liu, PhD, Shelton Earp, MD, and their collaborators reported discoveries about a key signaling pathway that can be hyperactive in kidney cancer.
